Literature DB >> 19863547

Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population.

S Lévesque1, C Dombrowski, M-L Morel, R Rehel, J-S Côté, J Bussières, K Morgan, F Rousseau.   

Abstract

To study the instability of FMR1 triplet repeats in the general population, we screened a prospective sample of 24,449 anonymized mother-offspring pairs and analyzed transmissions of intermediate-size (45-54 triplets) and premutation-size (55-200 triplets) alleles. We screened all mothers for alleles > or = 45 triplets by Southern blot and studied transmission of 545 maternal alleles to their offspring using polymerase chain reaction. Out of 21,411 maternal samples with conclusive results, we identified 250 carriers of at least one intermediate-size allele and 39 carrying a premutation-size allele. Out of a subsample of 430 transmissions of normal-size alleles (< 45 triplets), we observed four (< 1%) unstable transmissions. There were 6/90 intermediate-size unstable alleles (7%) and 11/25 unstable premutation-size alleles (44%). Two mothers transmitted a typical full mutation. The incidence of fragile X syndrome was thus 1/12,225 newborns (upper limit of 95% confidence interval: 1/4638 newborns), but larger in males (1/6209) than females (none detected in over 12,000 newborn females). Intermediate-size alleles were more unstable than normal-size alleles (p = 0.0027), but more stable (about sixfold) than premutation-size alleles (p < 0.0001). Unstable premutation-size alleles harbored the major fragile X haplotype (T50-T42-T62), and this haplotype appeared to be a good predictor of instability in premutations (p = 0.02). Incidence and instability are important to determine the feasibility and cost effectiveness of putative FMR1 screening programs. Carriers of FMR1 alleles of 55+ triplets with no family history of the disease may have a significant risk of expansion to a full mutation in a single generation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19863547     DOI: 10.1111/j.1399-0004.2009.01237.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

Review 2.  Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.

Authors:  Daman Kumari; Rachel Lokanga; Dmitry Yudkin; Xiao-Nan Zhao; Karen Usdin
Journal:  Biochim Biophys Acta       Date:  2012-01-05

3.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

4.  Intermediate FMR1 alleles and cognitive and/or behavioural phenotypes.

Authors:  Irene Madrigal; Mar Xunclà; Maria Isabel Tejada; Francisco Martínez; Isabel Fernández-Carvajal; Luís Alberto Pérez-Jurado; Laia Rodriguez-Revenga; Montserrat Milà
Journal:  Eur J Hum Genet       Date:  2011-03-23       Impact factor: 4.246

5.  Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency.

Authors:  Sebastien Jacquemont; Stefanie Birnbaum; Silke Redler; Peter Steinbach; Valérie Biancalana
Journal:  Eur J Hum Genet       Date:  2011-05-04       Impact factor: 4.246

6.  Maternal FMR1 alleles expansion in newborns during transmission: a prospective cohort study.

Authors:  Rabia Shahid; Muhammad Yasin; Zia Ur Rehman; Humaira Jadoon; Haleema Tahir; Neelam Meraj; Niamat Khan; Maria Zubair; Irba Zulfiqar; Maha Nowshid; Arfa Azeem; Musarrat Jabeen; Abdul Hameed; Shamim Saleha
Journal:  Pediatr Res       Date:  2022-06-09       Impact factor: 3.756

7.  Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.

Authors:  Atefeh Entezari; Mahmoud Shekari Khaniani; Tayyeb Bahrami; Sima Mansoori Derakhshan; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-10-01       Impact factor: 3.307

8.  Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors.

Authors:  Brenda Finucane; Liane Abrams; Amy Cronister; Alison D Archibald; Robin L Bennett; Allyn McConkie-Rosell
Journal:  J Genet Couns       Date:  2012-07-14       Impact factor: 2.537

9.  Fragile X protein in newborn dried blood spots.

Authors:  Tatyana Adayev; Giuseppe LaFauci; Carl Dobkin; Michele Caggana; Veronica Wiley; Michael Field; Tiffany Wotton; Richard Kascsak; Sarah L Nolin; Anne Glicksman; Nicole Hosmer; W Ted Brown
Journal:  BMC Med Genet       Date:  2014-10-28       Impact factor: 2.103

10.  Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Elaine Spector; Andrea Behlmann; Kathryn Kronquist; Nancy C Rose; Elaine Lyon; Honey V Reddi
Journal:  Genet Med       Date:  2021-04-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.